covid 19 News and Research

RSS

Novel non-extensive statistical model to study COVID-19 epidemic distribution

Researchers modified and developed a SIR model within the framework of non-extensive statistics to show the complexity of the global COVID-19 epidemic distribution.

23 Mar 2022

INTEGRA’s ASSIST PLUS pipetting robot helps to streamline sample pooling for arbovirus testing

INTEGRA Biosciences’ ASSIST PLUS pipetting robot is helping the Arbovirus Testing Lab at the New Hampshire Public Health Laboratories in Concord, USA, to streamline sample pooling for West Nile and Eastern equine encephalitis virus testing.

From INTEGRA Biosciences 23 Mar 2022

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

Study shows link between psychotropic medication use and post-Covid dementia

Recent studies have highlighted the connection between coronavirus disease 2019 (COVID-19) infection and the development of dementia.

23 Mar 2022

Seafood workers twice as likely to contract COVID-19 as workers in other food industries

The dramatic toll that COVID-19 has taken on the U.S. is apparent, but as caseloads come down and mandates are loosened it has become increasingly obvious how much of an impact the pandemic had on food service workers in industries like the fisheries.

23 Mar 2022

Importance of Numb-associated kinases in SARS-CoV-2 infection

A new study posted to the bioRxiv* preprint server has focussed on assessing four members of the NAK family that are associated with SARS-CoV-2 infection. These kininases could act as a target for the development of effective COVID-19 therapeutics.

23 Mar 2022

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

It is becoming increasingly clear that individuals recovering from acute coronavirus disease (COVID-19) may develop post-acute sequelae (Post-Acute Coronavirus Syndrome, PACS).

23 Mar 2022

Breakthrough hospitalizations for COVID-19, less likely to happen in vaccinated or previously infected people

Fewer than 1 in 1,000 people who have been vaccinated or previously infected with COVID-19 were hospitalized with a new breakthrough infection, Mayo Clinic research finds.

22 Mar 2022

Study reveals differences in SARS-CoV-2 and SARS-CoV-1 spike protein conformational changes

Researchers determine the differential dynamic behavior of SARS-CoV-1 and SARS-CoV-2 spike proteins.

22 Mar 2022

New model suggests long-range transmission of SARS-CoV-2

A new study describes the long-range transmission of SARS-CoV-2 through aerosolized particles as a possibility.

22 Mar 2022

Monitoring SARS-CoV-2 Ct values during early infection

A new study tracks the fluctuations in viral load in people recently infected with SARS-CoV-2.

22 Mar 2022

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

Researchers report the results for a new SARS-CoV-2 vaccine currently in Phase III clinical trial known as I53-50.

22 Mar 2022

COVID booster vaccination more effective relative to 2-dose series

A booster dose of a mRNA-based COVID-19 vaccine is more effective than the two-dose primary vaccination regimen in preventing SARS-CoV-2 infections.

22 Mar 2022

Powerful tool to monitor membrane proteins trafficking for drug discovery

Inside your body on the surface of cell membranes, a metaphorical communication and traffic network is underway as hormones - or chemical messengers - bind to cell membrane receptors to fine tune how the cell behaves.

22 Mar 2022

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

Scientists at the University of North Carolina at Chapel Hill are testing a new route for remdesivir, a pill form of the COVID-19 treatment that’s given to half of all hospitalized patients with the disease.

22 Mar 2022

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.

22 Mar 2022

PROCOVAXED: Promoting COVID vaccination in emergency departments

Researchers examine the reasons behind COVID-19 vaccine hesitancy emergency department patients when educated through vaccine messaging platforms.

22 Mar 2022

Rubella antibodies vs. COVID-19

A new study describes a potential relationship between antibody titers against the rubella virus and the severity of COVID-19.

22 Mar 2022

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

Scientists have worked extensively hard to contain the COVID-19 pandemic caused by the rapid transmission of SARS-CoV-2.

22 Mar 2022

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Researchers have determined the effect of booster immunization on the levels of antibodies generated, against SARS-CoV-2 variants, including the Omicron strain, in cancer patients with or without active B cell-targeted therapy.

22 Mar 2022

covid 19 News and Research

Novel non-extensive statistical model to study COVID-19 epidemic distribution

INTEGRA’s ASSIST PLUS pipetting robot helps to streamline sample pooling for arbovirus testing

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

Study shows link between psychotropic medication use and post-Covid dementia

Seafood workers twice as likely to contract COVID-19 as workers in other food industries

Importance of Numb-associated kinases in SARS-CoV-2 infection

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

Breakthrough hospitalizations for COVID-19, less likely to happen in vaccinated or previously infected people

Study reveals differences in SARS-CoV-2 and SARS-CoV-1 spike protein conformational changes

New model suggests long-range transmission of SARS-CoV-2

Monitoring SARS-CoV-2 Ct values during early infection

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

COVID booster vaccination more effective relative to 2-dose series

Powerful tool to monitor membrane proteins trafficking for drug discovery

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

PROCOVAXED: Promoting COVID vaccination in emergency departments

Rubella antibodies vs. COVID-19

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News